Clinical Trial Update: Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 randomized trial is investigating ozone therapy for chemotherapy-induced peripheral neuropathy and related neuropathic pain; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain

Drugs mentioned

• Ozone Therapy

Snippet

Sponsor: Bernardino Clavo, MD, PhD | Conditions: Chemotherapy-induced Peripheral Neuropathy, Pain, Neuropathic | Phase 2, Phase 3 | Status: RECRUITING